CXCR4 and acute myeloid leukemia: Moreover, our results showed that repeated intravenous injections of this nanotoxin blocked CXCR4+ leukemic cell dissemination in the BM and liver in a CXCR4+ AML mouse model without causing on-target or off-target toxicity.